9ML8
 
 | |
9ML9
 
 | |
9MRW
 
 | Functional Implications of Hexameric Dynamics in SARS-CoV-2 Nsp15 | 分子名称: | Uridylate-specific endoribonuclease nsp15 | 著者 | Ketawala, G.K, Sonowal, M, Schrag, L, Fromme, R, Botha, S, Fromme, P. | 登録日 | 2025-01-08 | 公開日 | 2025-06-04 | 実験手法 | X-RAY DIFFRACTION (3 Å) | 主引用文献 | Functional implications of hexameric dynamics in SARS-CoV-2 Nsp15. Protein Sci., 34, 2025
|
|
9MRY
 
 | Functional Implications of HexamericDynamics in SARS-CoV-2 Nsp15 | 分子名称: | Uridylate-specific endoribonuclease nsp15 | 著者 | Ketawala, G.K, Sonowal, M, Schrag, L, Fromme, R, Botha, S, Fromme, P. | 登録日 | 2025-01-09 | 公開日 | 2025-06-04 | 実験手法 | X-RAY DIFFRACTION (3 Å) | 主引用文献 | Functional implications of hexameric dynamics in SARS-CoV-2 Nsp15. Protein Sci., 34, 2025
|
|
8XCH
 
 | |
8ZPQ
 
 | |
8ZQ8
 
 | |
8ZT9
 
 | The Crystal structure of mol066 bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 | 分子名称: | 3C-like proteinase, 6-[(6-chloranyl-2-propan-2-yl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione, GLYCEROL | 著者 | Yan, M, Zhang, H. | 登録日 | 2024-06-06 | 公開日 | 2025-06-11 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CL pro ) inhibitors with anti-coronavirus activities. Bioorg.Chem., 154, 2025
|
|
8ZUC
 
 | The Crystal structure of mol080 bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 | 分子名称: | 3C-like proteinase, 6-[[6-chloranyl-2-(3-methylbutyl)indazol-5-yl]amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione | 著者 | Yan, M, Zhang, H. | 登録日 | 2024-06-08 | 公開日 | 2025-06-11 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CL pro ) inhibitors with anti-coronavirus activities. Bioorg.Chem., 154, 2025
|
|
9FC2
 
 | The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing nanobody 4. | 分子名称: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, ... | 著者 | Casasnovas, J.M, Fernandez, L.A, Silva, K. | 登録日 | 2024-05-15 | 公開日 | 2025-06-11 | 実験手法 | X-RAY DIFFRACTION (1.21 Å) | 主引用文献 | Integrating immune library probing with structure-based computational design to develop potent neutralizing nanobodies against emerging SARS-CoV-2 variants. Mabs, 17, 2025
|
|
9GUB
 
 | SARS-CoV-2 Mac1 in complex with MCD-628 | 分子名称: | (2~{S})-3-(1~{H}-indol-3-yl)-2-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-ylamino)propanoic acid, Papain-like protease nsp3 | 著者 | Duong, M, Paakkonen, J, Lehtio, L. | 登録日 | 2024-09-19 | 公開日 | 2025-06-11 | 最終更新日 | 2025-06-25 | 実験手法 | X-RAY DIFFRACTION (1.1 Å) | 主引用文献 | Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication. Mbio, 16, 2025
|
|
9NPX
 
 | |
9C7X
 
 | |
9EEI
 
 | |
9IKZ
 
 | SARS-CoV-2 E-RTC bound to pRNA-nsp9 and GDP-BeF3- | 分子名称: | BERYLLIUM TRIFLUORIDE ION, GUANOSINE-5'-DIPHOSPHATE, Helicase nsp13, ... | 著者 | Yan, L.M, Huang, Y.C, Liu, Y.X, Rao, Z.H, Lou, Z.Y. | 登録日 | 2024-06-29 | 公開日 | 2025-06-18 | 実験手法 | ELECTRON MICROSCOPY (3.14 Å) | 主引用文献 | Substrate selection and transition reveal the mechanism for RNA capping catalyzed by SARS-CoV-2 NiRAN To Be Published
|
|
9VAO
 
 | Crystal structure of Papain-like protease (PLpro) from SARS-CoV-2 | 分子名称: | GLYCEROL, PHOSPHATE ION, Papain-like protease nsp3, ... | 著者 | Arya, R, Ganesh, J, Prashar, V, Kumar, M. | 登録日 | 2025-06-03 | 公開日 | 2025-06-18 | 実験手法 | X-RAY DIFFRACTION (1.82 Å) | 主引用文献 | Crystal structure of Papain-like protease (PLpro) from SARS-CoV-2 To Be Published
|
|
9CPP
 
 | |
9CPQ
 
 | |
9CPR
 
 | |
9CPS
 
 | |
9CPT
 
 | |
9CPU
 
 | |
9CPV
 
 | |
9CPW
 
 | |
9CPX
 
 | |